Joan Neyra
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Joan Neyra has a total of 87 co-authors. Here are the top co-authors by number of shared publications:
Candice Romero
Vysnova Partners, Inc. (assigned to Clinical Trials Unit, NAMRU SOUTH) , Alexandria, Virginia
6 shared publicationsAlejandro Llanos-Cuentas
Infectious Diseases and Tropical Medicine Department, Cayetano Heredia Hospital , Lima
3 shared publicationsDiana Ponce
Vysnova Partners, Inc. (assigned to Clinical Trials Unit, NAMRU SOUTH) , Alexandria, Virginia
3 shared publications- Eduardo Matos
Infectious Diseases Department, Arzobispo Loayza National Hospital , Lima
3 shared publications Giselle Soto
U. S. Naval Medical Research Unit SOUTH (NAMRU SOUTH)
3 shared publications- Giselle Soto
Clinical Trials Unit, U.S. Naval Medical Unit Research SOUTH (NAMRU SOUTH) , Lima
3 shared publications
Latest Publications
- Open Access
Toward a National Registry for Inborn Errors of Immunity in Peru: A Qualitative Implementation Study
Background: Peru lacks an integrated information system for patients with Inborn Errors of Immunity (IEI). Although disease registries are essential tools for data management and health planning, their success depends on implementation science approaches that account for local contextual factors. This study reports Phase I of a three-phase mixed-methods implementation project to design and develop a national IEI registry. Methods: Phase I consisted of a phenomenological qualitative study exploring stakeholder perspectives. Semi-structured focus groups and in-depth interviews were conducted with 29 key stakeholders across four groups: policy-makers, clinical experts, end-users (immunologists, residents, allied health personnel), and patient organization representatives. Interviews followed a guide structured around four a priori domains (structure, navigation, feasibility, and perception of existing systems). Discussions were conducted in Spanish, audio-recorded, transcribed verbatim, and coded using ATLAS.ti. A hybrid thematic analysis combining deductive and inductive coding was performed. Data elements proposed for the registry were triangulated with qualitative findings. Results: Thirty-six initial codes were consolidated into 15 categories, which were further integrated into four overarching themes conceptualized as pathways toward intention to use: (1) Environment, where governance, regulatory backing, and sustainable financing were identified as key enablers, while limited interoperability emerged as a structural barrier; (2) Technical Dimension, emphasizing usability, alignment with clinical workflow, and a hierarchical data architecture (demographic–clinical–therapeutic); (3) Users, highlighting clinical leadership, protected time, digital readiness, and perceived usefulness as stronger motivators than financial incentives; and (4) Patients, underscoring data protection, transparency, trust, and advocacy as essential for legitimacy and sustainability. Conclusions: A national IEI registry in Peru is perceived as necessary and feasible if implemented with strong regulatory foundations, interoperable design, robust data security, and user-centered architecture. These findings informed the development of an initial functional prototype and the operational plan for Phase II, focused on usability evaluation.
Open AccessToward a National Registry for Inborn Errors of Immunity in Peru: A Qualitative Implementation Study
Background: Peru lacks an integrated information system for patients with Inborn Errors of Immunity (IEI). Although disease registries are essential tools for data management and health planning, their success depends on implementation science approaches that account for local contextual factors. This study reports Phase I of a three-phase mixed-methods implementation project to design and develop a national IEI registry. Methods: Phase I consisted of a phenomenological qualitative study exploring stakeholder perspectives. Semi-structured focus groups and in-depth interviews were conducted with 29 key stakeholders across four groups: policy-makers, clinical experts, end-users (immunologists, residents, allied health personnel), and patient organization representatives. Interviews followed a guide structured around four a priori domains (structure, navigation, feasibility, and perception of existing systems). Discussions were conducted in Spanish, audio-recorded, transcribed verbatim, and coded using ATLAS.ti. A hybrid thematic analysis combining deductive and inductive coding was performed. Data elements proposed for the registry were triangulated with qualitative findings. Results: Thirty-six initial codes were consolidated into 15 categories, which were further integrated into four overarching themes conceptualized as pathways toward intention to use: (1) Environment, where governance, regulatory backing, and sustainable financing were identified as key enablers, while limited interoperability emerged as a structural barrier; (2) Technical Dimension, emphasizing usability, alignment with clinical workflow, and a hierarchical data architecture (demographic–clinical–therapeutic); (3) Users, highlighting clinical leadership, protected time, digital readiness, and perceived usefulness as stronger motivators than financial incentives; and (4) Patients, underscoring data protection, transparency, trust, and advocacy as essential for legitimacy and sustainability. Conclusions: A national IEI registry in Peru is perceived as necessary and feasible if implemented with strong regulatory foundations, interoperable design, robust data security, and user-centered architecture. These findings informed the development of an initial functional prototype and the operational plan for Phase II, focused on usability evaluation.
- Open Access
Implementing a National Registry of Patients with Inborn Errors of Immunity in Peru: A Mixed-Methods Protocol
Background Inborn errors of immunity (IEIs) include more than 500 genetic disorders that cause recurrent infections, autoimmunity, and inflammatory complications. Although classified as rare diseases, their prevalence is increasing, making IEI an emerging public health problem. However, reliable national epidemiological data and coordinated follow-up data of IEI patients are lacking, which potentially affects up to 20,000 people in Peru. Objective In this study, we aim to describe the protocol of a three-phase mixed-method study that will design, build, and evaluate the usability and feasibility of the first Peruvian National IEI Registry. Methods Guided by the Exploration-Preparation-Implementation-Sustainment (EPIS) framework, Phase I (qualitative) will map stakeholder needs through in-depth interviews and focus groups; the data will undergo hybrid thematic analysis in ATLAS.ti. Phase II (pre-experimental) will enroll ≥20 clinical immunology consultants and residents to complete standardized tasks on the REDCap-based prototype; efficiency (task time), effectiveness (error rate), and satisfaction will be compared pre/post-iteration. Phase III (observational) will assess feasibility by enrolling ≥126 IEI cases across six national reference hospitals; the primary outcomes are clinical profile, data completeness, and accuracy. Results The study protocol received institutional review board approval in February 2025 from the UNMSM-Research Ethics Committee. Phase I enrollment started in March 2025. We expect our REDCap-based prototype to incorporate key needs and preferences gathered from focus groups and interviews to develop the platform. By the completion of the study phase II, we will have assessed the usability of the prototype platform. Study phase III will begin in April 2026. The final results are expected by November 2026 and will be published thereafter. Conclusions By evaluating usability and feasibility in real-world conditions, this protocol lays the groundwork for a national IEI registry. The resulting evidence will inform scale-up decisions and facilitate its incorporation into Peruvian health policy. Contributions to the literature - Shows how the EPIS framework can steer real-world adoption of a REDCap-based registry and prospectively measure usability and feasibility across six public hospitals involved in rare-disease surveillance. - Provides a mixed-methods protocol that designs, iterates and field-tests Peru’s first national registry for inborn errors of immunity, tackling persistent barriers to rare-disease data capture in low- and middle-income countries and offering a scalable blueprint for other resource-constrained settings. - Outlines a FAIR-aligned governance and data-sharing strategy that can be adapted by future programmes planning registries for rare and orphan diseases in similar contexts.
Open AccessImplementing a National Registry of Patients with Inborn Errors of Immunity in Peru: A Mixed-Methods Protocol
Background Inborn errors of immunity (IEIs) include more than 500 genetic disorders that cause recurrent infections, autoimmunity, and inflammatory complications. Although classified as rare diseases, their prevalence is increasing, making IEI an emerging public health problem. However, reliable national epidemiological data and coordinated follow-up data of IEI patients are lacking, which potentially affects up to 20,000 people in Peru. Objective In this study, we aim to describe the protocol of a three-phase mixed-method study that will design, build, and evaluate the usability and feasibility of the first Peruvian National IEI Registry. Methods Guided by the Exploration-Preparation-Implementation-Sustainment (EPIS) framework, Phase I (qualitative) will map stakeholder needs through in-depth interviews and focus groups; the data will undergo hybrid thematic analysis in ATLAS.ti. Phase II (pre-experimental) will enroll ≥20 clinical immunology consultants and residents to complete standardized tasks on the REDCap-based prototype; efficiency (task time), effectiveness (error rate), and satisfaction will be compared pre/post-iteration. Phase III (observational) will assess feasibility by enrolling ≥126 IEI cases across six national reference hospitals; the primary outcomes are clinical profile, data completeness, and accuracy. Results The study protocol received institutional review board approval in February 2025 from the UNMSM-Research Ethics Committee. Phase I enrollment started in March 2025. We expect our REDCap-based prototype to incorporate key needs and preferences gathered from focus groups and interviews to develop the platform. By the completion of the study phase II, we will have assessed the usability of the prototype platform. Study phase III will begin in April 2026. The final results are expected by November 2026 and will be published thereafter. Conclusions By evaluating usability and feasibility in real-world conditions, this protocol lays the groundwork for a national IEI registry. The resulting evidence will inform scale-up decisions and facilitate its incorporation into Peruvian health policy. Contributions to the literature - Shows how the EPIS framework can steer real-world adoption of a REDCap-based registry and prospectively measure usability and feasibility across six public hospitals involved in rare-disease surveillance. - Provides a mixed-methods protocol that designs, iterates and field-tests Peru’s first national registry for inborn errors of immunity, tackling persistent barriers to rare-disease data capture in low- and middle-income countries and offering a scalable blueprint for other resource-constrained settings. - Outlines a FAIR-aligned governance and data-sharing strategy that can be adapted by future programmes planning registries for rare and orphan diseases in similar contexts.
- Open Access
- 19 August 2025
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 81 (3) , 459-466
Evaluation of COVID-19 and Influenza-like Illness Surveillance Case Definitions in a Prospective Cohort of Healthcare Personnel in Peru
Background: Public health agencies employ case definitions for influenza virus and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections to optimize surveillance, monitor disease trends, and inform decision-making, particularly in limited resource settings. Methods: Using a prospective healthcare personnel cohort in two hospitals in Lima, Peru (July 2022–June 2023), we compared and evaluated the performance of three symptom profiles of three common surveillance case definitions to identify influenza and SARS-CoV-2 infections: influenza-like illness, coronavirus disease 2019–like illness (CLI), and acute respiratory infection. Participants with an acute respiratory illness reported symptom progression twice weekly. Participants self-collected nasal swabs for SARS-CoV-2 and influenza reverse transcription real-time polymerase chain reaction testing. Sensitivity, specificity, and positive and negative predictive values of each case definition were evaluated. Results: Of 1623 participants enrolled, 1450 illness episodes were reported; 92 (6%) were positive for influenza, 350 (24%) for SARS-CoV-2, and 3 (0.2%) were positive for both. For the four influenza-like illness case definitions evaluated, all yielded low sensitivity for detection of influenza (points estimate range, 23%–35%) and SARS-COV-2 (range, 21%–29%), but high specificity (83%–90% and 86%–92%, respectively). In contrast, the acute respiratory infection and coronavirus disease 2019–like illness definitions both yielded high sensitivity (83%–100%) and low specificity (2%–41%) for detection of both influenza and SARS-CoV-2. Conclusions: The performance of case definitions was similar for influenza and SARS-CoV-2 supporting the use of the same definitions by surveillance networks. The substantial differences in sensitivity and specificity across the case definitions necessitate surveillance objectives and cost considerations in selecting a case definition fit for purpose.
- 19 August 2025
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 81 (3) , 459-466
Open AccessEvaluation of COVID-19 and Influenza-like Illness Surveillance Case Definitions in a Prospective Cohort of Healthcare Personnel in Peru
Background: Public health agencies employ case definitions for influenza virus and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections to optimize surveillance, monitor disease trends, and inform decision-making, particularly in limited resource settings. Methods: Using a prospective healthcare personnel cohort in two hospitals in Lima, Peru (July 2022–June 2023), we compared and evaluated the performance of three symptom profiles of three common surveillance case definitions to identify influenza and SARS-CoV-2 infections: influenza-like illness, coronavirus disease 2019–like illness (CLI), and acute respiratory infection. Participants with an acute respiratory illness reported symptom progression twice weekly. Participants self-collected nasal swabs for SARS-CoV-2 and influenza reverse transcription real-time polymerase chain reaction testing. Sensitivity, specificity, and positive and negative predictive values of each case definition were evaluated. Results: Of 1623 participants enrolled, 1450 illness episodes were reported; 92 (6%) were positive for influenza, 350 (24%) for SARS-CoV-2, and 3 (0.2%) were positive for both. For the four influenza-like illness case definitions evaluated, all yielded low sensitivity for detection of influenza (points estimate range, 23%–35%) and SARS-COV-2 (range, 21%–29%), but high specificity (83%–90% and 86%–92%, respectively). In contrast, the acute respiratory infection and coronavirus disease 2019–like illness definitions both yielded high sensitivity (83%–100%) and low specificity (2%–41%) for detection of both influenza and SARS-CoV-2. Conclusions: The performance of case definitions was similar for influenza and SARS-CoV-2 supporting the use of the same definitions by surveillance networks. The substantial differences in sensitivity and specificity across the case definitions necessitate surveillance objectives and cost considerations in selecting a case definition fit for purpose.
- Open Access
- 29 July 2025
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 81 (3) , 467-477
COVID-19 Exposure, Protective Measures, Symptom Assessment, and Risk Perception Among Healthcare Workers in Peru: A Longitudinal Cohort Study (2020–2021)
Background: The coronavirus disease 2019 (COVID-19) pandemic placed significant pressure on healthcare workers (HCWs) globally, exposing them to high risks of infection and psychological stress. This study assessed dynamic risks and protective factors for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among HCWs in Lima, Peru. Methods: We conducted the Peru Healthcare Worker COVID Cohort (PHCWCC), a prospective cohort study during the pre-COVID-19 vaccination period (August 2020–May 2021) and the post-vaccination period (August 2021–May 2022). Data included weekly nasal swabs for SARS-CoV-2 testing, reports on exposures, symptoms, perceived risks, and vaccination status. Incidence and factors associated with SARS-CoV-2 positivity were analyzed. Results: Among 1369 HCWs, the infection rate increased from 1.15 (95% confidence interval [CI]: .90–1.14) to 1.71 (95% CI: 1.41–2.05) per 1000 HCW-days between the pre- and post-vaccination phases (P = .01). Despite 97% receiving the primary vaccine series and 75% a booster, perceived high infection risk rose from 26% to 35% (P < .001). Close contact with infected colleagues remained a consistent risk factor (odds ratio [OR] = 2.74, 95% CI: 1.85–4.05; P < .001). In the second phase, direct patient contact (OR = 1.92, 95% CI: 1.20–3.08; P = .006) and patient care environments (OR = 2.14, 95% CI: 1.35–3.40; P = .001) were linked to higher infection risk. Perceived infection risk was inversely associated with positivity (OR = 0.76, 95% CI: 0.63–0.91; P = .003). Conclusions: Evolving infection risks highlight the need for sustained infection prevention, including during non-patient care activities. Fostering risk awareness may reduce infection rates and strengthen healthcare system resilience.
- 29 July 2025
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 81 (3) , 467-477
Open AccessCOVID-19 Exposure, Protective Measures, Symptom Assessment, and Risk Perception Among Healthcare Workers in Peru: A Longitudinal Cohort Study (2020–2021)
Background: The coronavirus disease 2019 (COVID-19) pandemic placed significant pressure on healthcare workers (HCWs) globally, exposing them to high risks of infection and psychological stress. This study assessed dynamic risks and protective factors for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among HCWs in Lima, Peru. Methods: We conducted the Peru Healthcare Worker COVID Cohort (PHCWCC), a prospective cohort study during the pre-COVID-19 vaccination period (August 2020–May 2021) and the post-vaccination period (August 2021–May 2022). Data included weekly nasal swabs for SARS-CoV-2 testing, reports on exposures, symptoms, perceived risks, and vaccination status. Incidence and factors associated with SARS-CoV-2 positivity were analyzed. Results: Among 1369 HCWs, the infection rate increased from 1.15 (95% confidence interval [CI]: .90–1.14) to 1.71 (95% CI: 1.41–2.05) per 1000 HCW-days between the pre- and post-vaccination phases (P = .01). Despite 97% receiving the primary vaccine series and 75% a booster, perceived high infection risk rose from 26% to 35% (P < .001). Close contact with infected colleagues remained a consistent risk factor (odds ratio [OR] = 2.74, 95% CI: 1.85–4.05; P < .001). In the second phase, direct patient contact (OR = 1.92, 95% CI: 1.20–3.08; P = .006) and patient care environments (OR = 2.14, 95% CI: 1.35–3.40; P = .001) were linked to higher infection risk. Perceived infection risk was inversely associated with positivity (OR = 0.76, 95% CI: 0.63–0.91; P = .003). Conclusions: Evolving infection risks highlight the need for sustained infection prevention, including during non-patient care activities. Fostering risk awareness may reduce infection rates and strengthen healthcare system resilience.
- 10 February 2025
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 231 (Supplement) , S25-S30
Influenza Virus Surveillance in Healthcare Personnel in Peru: NAMRU SOUTH Experience and Perspective
Vaccinating healthcare personnel (HCP) is a top priority for public health globally. This strategy aims not only to protect HCP but also patients, reducing transmission of infections in healthcare services. However, improving vaccine coverage in HCP is still a challenge, especially because they are a risk group for acquiring influenza. Multicomponent influenza vaccination programs targeting behavioral, organizational, and administrative barriers are critical to ensure this priority population is vaccinated. Here, we describe a healthcare worker cohort study that was implemented in Peru, a middle-income country, in 2016, prior to the coronavirus disease 2019 pandemic. This cohort, which is still ongoing, has collected valuable information on influenza vaccine effectiveness, vaccine coverage, risk factors, absenteeism, and use of personal protective equipment, as well as risk of influenza disease, among others. These data can help improve knowledge not only about influenza diseases but also regarding vaccination on this specific influenza risk group in order to improve vaccine uptake.
- 10 February 2025
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 231 (Supplement) , S25-S30
Influenza Virus Surveillance in Healthcare Personnel in Peru: NAMRU SOUTH Experience and Perspective
Vaccinating healthcare personnel (HCP) is a top priority for public health globally. This strategy aims not only to protect HCP but also patients, reducing transmission of infections in healthcare services. However, improving vaccine coverage in HCP is still a challenge, especially because they are a risk group for acquiring influenza. Multicomponent influenza vaccination programs targeting behavioral, organizational, and administrative barriers are critical to ensure this priority population is vaccinated. Here, we describe a healthcare worker cohort study that was implemented in Peru, a middle-income country, in 2016, prior to the coronavirus disease 2019 pandemic. This cohort, which is still ongoing, has collected valuable information on influenza vaccine effectiveness, vaccine coverage, risk factors, absenteeism, and use of personal protective equipment, as well as risk of influenza disease, among others. These data can help improve knowledge not only about influenza diseases but also regarding vaccination on this specific influenza risk group in order to improve vaccine uptake.
- 10 February 2025
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 231 (Supplement) , S19-S24
Norovirus Surveillance and Outbreak Investigations in Peru: 25 Years of Experience at NAMRU SOUTH
Norovirus is the worldwide leading cause of gastroenteric diseases. It affects mainly infants and older adults, but the findings are mainly derived from outbreak investigations rather than population-based cohorts. The U. S. Naval Medical Research Unit SOUTH (NAMRU SOUTH) developed and conducted research studies in the last 20 years focusing on the military and general populations afflicted by this pathogen. For the latter, studies included all age groups in 2 main communities in Peru, representing people from the highlands and tropical areas. The results helped elucidate the incidence of norovirus infection among different age groups as well as identifying risk factors, seasonality, and economic burden on the patient. The collected data demonstrate an increase of norovirus cases, not only in the previously reported age groups but also in adults. Consequently, this increase of norovirus cases in adults may impair the occupational productivity in civilian populations and operational readiness among service members.
- 10 February 2025
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 231 (Supplement) , S19-S24
Norovirus Surveillance and Outbreak Investigations in Peru: 25 Years of Experience at NAMRU SOUTH
Norovirus is the worldwide leading cause of gastroenteric diseases. It affects mainly infants and older adults, but the findings are mainly derived from outbreak investigations rather than population-based cohorts. The U. S. Naval Medical Research Unit SOUTH (NAMRU SOUTH) developed and conducted research studies in the last 20 years focusing on the military and general populations afflicted by this pathogen. For the latter, studies included all age groups in 2 main communities in Peru, representing people from the highlands and tropical areas. The results helped elucidate the incidence of norovirus infection among different age groups as well as identifying risk factors, seasonality, and economic burden on the patient. The collected data demonstrate an increase of norovirus cases, not only in the previously reported age groups but also in adults. Consequently, this increase of norovirus cases in adults may impair the occupational productivity in civilian populations and operational readiness among service members.
- Open Access
- 21 November 2024
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 150, 107308
Epidemiology of norovirus disease in the first 2 years of life: A prospective multisite cohort study in Lima, Peru
- 21 November 2024
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 150, 107308
Open AccessEpidemiology of norovirus disease in the first 2 years of life: A prospective multisite cohort study in Lima, Peru
- Open Access
- 10 July 2024
- Published by Public Library of Science (PLoS) in PLOS Global Public Health
- Vol. 4 (7) , e0002748
Household economic costs of norovirus gastroenteritis in two community cohorts in Peru, 2012–2019
While costs of norovirus acute gastroenteritis (AGE) to healthcare systems have been estimated, out-of-pocket and indirect costs incurred by households are not well documented in community settings, particularly in developing countries. We conducted active surveillance for AGE in two communities in Peru: Puerto Maldonado (October 2012–August 2015) and San Jeronimo (April 2015–April 2019). Norovirus AGE events with PCR-positive stool specimens were included. Data collected in follow-up interviews included event-related medical resource utilization, associated out-of-pocket costs, and indirect costs. There were 330 norovirus-associated AGE events among 3,438 participants from 685 households. Approximately 49% of norovirus events occurred among children <5 years of age and total cost to the household per episode was highest in this age group. Norovirus events cost a median of US $2.95 (IQR $1.04–7.85) in out-of-pocket costs and $12.58 (IQR $6.39–25.16) in indirect costs. Medication expenses accounted for 53% of out-of-pocket costs, and productivity losses accounted for 59% of the total financial burden on households. The frequency and associated costs of norovirus events to households in Peruvian communities support the need for prevention strategies including vaccines. Norovirus interventions targeting children <5 years of age and their households may have the greatest economic benefit.
- 10 July 2024
- Published by Public Library of Science (PLoS) in PLOS Global Public Health
- Vol. 4 (7) , e0002748
Open AccessHousehold economic costs of norovirus gastroenteritis in two community cohorts in Peru, 2012–2019
While costs of norovirus acute gastroenteritis (AGE) to healthcare systems have been estimated, out-of-pocket and indirect costs incurred by households are not well documented in community settings, particularly in developing countries. We conducted active surveillance for AGE in two communities in Peru: Puerto Maldonado (October 2012–August 2015) and San Jeronimo (April 2015–April 2019). Norovirus AGE events with PCR-positive stool specimens were included. Data collected in follow-up interviews included event-related medical resource utilization, associated out-of-pocket costs, and indirect costs. There were 330 norovirus-associated AGE events among 3,438 participants from 685 households. Approximately 49% of norovirus events occurred among children <5 years of age and total cost to the household per episode was highest in this age group. Norovirus events cost a median of US $2.95 (IQR $1.04–7.85) in out-of-pocket costs and $12.58 (IQR $6.39–25.16) in indirect costs. Medication expenses accounted for 53% of out-of-pocket costs, and productivity losses accounted for 59% of the total financial burden on households. The frequency and associated costs of norovirus events to households in Peruvian communities support the need for prevention strategies including vaccines. Norovirus interventions targeting children <5 years of age and their households may have the greatest economic benefit.
- Open Access
- 26 January 2021
- Published by Taylor & Francis in Human Vaccines & Immunotherapeutics
- Vol. 17 (7) , 2176-2184
What do pregnant women think about influenza disease and vaccination practices in selected countries
Introduction: We evaluated knowledge, attitudes, and practices (KAP) related to influenza and influenza vaccination among pregnant women in three selected countries. Methods: During 2017, pregnant women seeking antenatal care at hospitals at participating sites were enrolled. We described characteristics and responses to KAP questions. We also evaluated predictors associated with influenza vaccination during pregnancy at sites with substantial influenza vaccine uptake by multivariable logistic regression. Results: Overall, 4,648 pregnant women completed the survey. There were substantial differences among the three survey populations; only 8% of the women in Nagpur had heard of influenza, compared to 90% in Lima and 96% in Bangkok (p-valuep < .05). For further analysis conducted among women in Lima only, household income above the poverty line (aOR: 1.38; 95%CI: 1.01, 1.88), having 8+ antenatal visits, compared to 0–4 (aOR: 2.41; 95%CI: 1.39, 2.87, respectively), having 0 children, compared to 2+ (aOR: 1.96; 95%CIs: 1.23, 3.12), and vaccination recommended by a health-care provider (aOR: 8.25; 95%CI: 6.11, 11.14) were strongly associated with receipt of influenza vaccine during pregnancy. Conclusions: Our findings identify opportunities for targeted interventions to improve influenza vaccine uptake among pregnant women in these settings.
- 26 January 2021
- Published by Taylor & Francis in Human Vaccines & Immunotherapeutics
- Vol. 17 (7) , 2176-2184
Open AccessWhat do pregnant women think about influenza disease and vaccination practices in selected countries
Introduction: We evaluated knowledge, attitudes, and practices (KAP) related to influenza and influenza vaccination among pregnant women in three selected countries. Methods: During 2017, pregnant women seeking antenatal care at hospitals at participating sites were enrolled. We described characteristics and responses to KAP questions. We also evaluated predictors associated with influenza vaccination during pregnancy at sites with substantial influenza vaccine uptake by multivariable logistic regression. Results: Overall, 4,648 pregnant women completed the survey. There were substantial differences among the three survey populations; only 8% of the women in Nagpur had heard of influenza, compared to 90% in Lima and 96% in Bangkok (p-valuep < .05). For further analysis conducted among women in Lima only, household income above the poverty line (aOR: 1.38; 95%CI: 1.01, 1.88), having 8+ antenatal visits, compared to 0–4 (aOR: 2.41; 95%CI: 1.39, 2.87, respectively), having 0 children, compared to 2+ (aOR: 1.96; 95%CIs: 1.23, 3.12), and vaccination recommended by a health-care provider (aOR: 8.25; 95%CI: 6.11, 11.14) were strongly associated with receipt of influenza vaccine during pregnancy. Conclusions: Our findings identify opportunities for targeted interventions to improve influenza vaccine uptake among pregnant women in these settings.